Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
12 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Lyvdelzi“
Suchtreffer
Begriffe & Kennungen
Lyvdelzi (previously Seladelpar Gilead) · 4.5 · Seladelpar is primarily metabolized in vitro by CYP2C9 and to a lesser extent by CYP2C8 and CYP3A4. Concomitan
Eintrag öffnenLyvdelzi (previously Seladelpar Gilead) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenLyvdelzi (previously Seladelpar Gilead) · 4.8 Undesirable effects · 1
Eintrag öffnenLyvdelzi (previously Seladelpar Gilead) · 4.8 · Based on clinical trial experience, the most frequently reported adverse reactions were abdominal pain (11.1%)
Eintrag öffnenLyvdelzi (previously Seladelpar Gilead) · 4.8 · Frequencies are defined according to the following convention: very common (≥ 1/10); common (≥ 1/100 to < 1/10
Eintrag öffnenLyvdelzi (previously Seladelpar Gilead) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenLyvdelzi (previously Seladelpar Gilead) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenLyvdelzi (previously Seladelpar Gilead) · 4.8 · Summary of safety profile
Eintrag öffnenLyvdelzi (previously Seladelpar Gilead) · 4.8 · System Organ Class Very Common Common Nervous System Disorders Headache Gastrointestinal Disorders Abdominal p
Eintrag öffnenLyvdelzi (previously Seladelpar Gilead) · 4.8 · Table 1: Adverse drug reactions reported in clinical trials in patients treated with seladelpar
Eintrag öffnenLyvdelzi (previously Seladelpar Gilead) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenLyvdelzi (previously Seladelpar Gilead) · 4.8 · The frequencies of the adverse drug reactions provided in the table below are based on pooled data from the RE
Eintrag öffnen